|
View results for a demographic group: |
Select a different topic: |
| View results for a different geographical area: |
|
| Total Respond.^ |
1 or more times/day | 1-6 times/week | Less than once a week | Never | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | % | C.I.(95%) | N | % | C.I.(95%) | N | % | C.I.(95%) | N | % | C.I.(95%) | ||
| TOTAL | 543 | 356 | 62.3 | 57.2-67.1 | 85 | 18.3 | 14.3-23.0 | 45 | 7.3 | 5.3-10.0 | 57 | 12.1 | 9.2-15.8 |
| GENDER | |||||||||||||
| Male | 224 | 142 | 62.2 | 54.8-69.1 | 38 | 17.2 | 12.3-23.6 | 19 | 8.8 | 5.4-13.8 | 25 | 11.8 | 7.6-17.7 |
| Female | 319 | 214 | 62.3 | 55.3-68.8 | 47 | 19.0 | 13.5-26.1 | 26 | 6.2 | 4.0- 9.5 | 32 | 12.4 | 8.7-17.5 |
| Have Health Insurance | |||||||||||||
| Yes | 497 | 327 | 62.9 | 57.6-67.9 | 77 | 18.1 | 14.0-23.2 | 44 | 7.7 | 5.6-10.7 | 49 | 11.2 | 8.3-15.0 |
| No | 45 | *** | *** | *** | *** | *** | *** | *** | *** | *** | *** | *** | *** |
| Body Mass Index | |||||||||||||
| Underweight | 3 | *** | *** | *** | *** | *** | *** | *** | *** | *** | *** | *** | *** |
| Recommended Range | 70 | *** | *** | *** | *** | *** | *** | *** | *** | *** | *** | *** | *** |
| Overweight | 157 | 95 | 56.1 | 46.7-65.1 | 30 | 21.3 | 14.1-30.7 | 15 | 9.7 | 5.5-16.4 | 17 | 13.0 | 7.8-20.9 |
| Obese | 270 | 182 | 64.7 | 57.8-71.1 | 43 | 17.2 | 12.5-23.2 | 21 | 6.9 | 4.3-10.9 | 24 | 11.2 | 7.3-16.7 |
| Current Smoker | |||||||||||||
| Yes | 64 | *** | *** | *** | *** | *** | *** | *** | *** | *** | *** | *** | *** |
| No | 461 | 296 | 60.6 | 55.0-66.0 | 77 | 19.8 | 15.4-25.2 | 37 | 6.8 | 4.7- 9.7 | 51 | 12.7 | 9.5-16.8 |
| History of CVD** | |||||||||||||
| Yes | 160 | 106 | 61.9 | 52.0-70.9 | 30 | 24.2 | 16.1-34.6 | 14 | 6.2 | 3.5-10.8 | *** | *** | *** |
| No | 373 | 242 | 62.1 | 56.1-67.8 | 54 | 16.1 | 11.8-21.5 | 30 | 7.4 | 5.0-10.9 | 47 | 14.3 | 10.6-19.1 |
| Binge Drinker | |||||||||||||
| Yes | 20 | *** | *** | *** | *** | *** | *** | *** | *** | *** | *** | *** | *** |
| No | 488 | 320 | 61.9 | 56.5-67.0 | 79 | 19.0 | 14.8-24.1 | 38 | 6.9 | 4.9- 9.8 | 51 | 12.2 | 9.1-16.1 |
| COPD | |||||||||||||
| Yes | 91 | *** | *** | *** | 16 | 19.2 | 11.5-30.4 | *** | *** | *** | *** | *** | *** |
| No | 449 | 289 | 60.6 | 55.0-66.0 | 68 | 17.5 | 13.2-22.8 | 40 | 8.2 | 5.8-11.4 | 52 | 13.6 | 10.3-17.9 |
| Current Asthma | |||||||||||||
| Yes | 79 | *** | *** | *** | *** | *** | *** | *** | *** | *** | *** | *** | *** |
| No | 461 | 298 | 61.1 | 55.5-66.4 | 72 | 18.9 | 14.5-24.3 | 42 | 8.0 | 5.7-11.1 | 49 | 12.0 | 8.9-16.0 |
| Functional Disability | |||||||||||||
| Yes | 310 | 201 | 60.5 | 53.6-67.1 | 55 | 20.6 | 15.1-27.4 | 24 | 7.5 | 4.8-11.6 | 30 | 11.3 | 7.7-16.3 |
| No | 218 | 145 | 64.7 | 56.9-71.8 | 29 | 15.8 | 10.6-23.0 | 20 | 7.2 | 4.4-11.5 | 24 | 12.3 | 8.0-18.5 |
| Has two or more chronic diseases† | |||||||||||||
| Yes | 424 | 278 | 61.8 | 56.0-67.4 | 69 | 19.3 | 14.6-24.9 | 35 | 6.9 | 4.8- 9.9 | 42 | 12.0 | 8.7-16.3 |
| No | 119 | 78 | 63.9 | 53.7-73.0 | 16 | 14.8 | 8.8-23.9 | *** | *** | *** | 15 | 12.6 | 7.3-20.9 |
*Asked of respondents with doctor-diagnosed diabetes. Respondents who reported having no feet excluded from this table.
**History of cardiovascular disease includes history of heart attack or coronary heart disease or stroke.
†Chronic diseases include heart disease (heart attack/stoke/angina), current asthma, skin cancer, other cancer, COPD, arthritis, depression, kidney disease and diabetes.
PLEASE NOTE: Due to changes in the weighting methodology and other factors, results from 2019 are NOT comparable to 2010
and earlier years.
***The estimate was suppressed because it did not meet statistical reliability standards. See BRFSS 2019 Annual Results Technical Notes for more details.
^Use caution in interpreting cell sizes less than 50, % = Percentage, C.I.(95%) = Confidence Interval (at 95 percent probability level).
Percentages are weighted to population characteristics and therefore cannot be calculated exactly from the numbers in this table.
BRFSS Home | Annual Questionnaires | Technical Notes
This page was generated on 09SEP20.
FOLLOW US